Author:
Zhang Haonan,Qiao Anna,Yang Linlin,Van Eps Ned,Frederiksen Klaus S.,Yang Dehua,Dai Antao,Cai Xiaoqing,Zhang Hui,Yi Cuiying,Cao Can,He Lingli,Yang Huaiyu,Lau Jesper,Ernst Oliver P.,Hanson Michael A.,Stevens Raymond C.,Wang Ming-Wei,Reedtz-Runge Steffen,Jiang Hualiang,Zhao Qiang,Wu Beili
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Drucker, D. J. The biology of incretin hormones. Cell Metab. 3, 153–165 (2006)
2. Mulder, J. E., Kolatkar, N. S. & LeBoff, M. S. Drug insight: existing and emerging therapies for osteoporosis. Nat. Clin. Pract. Endocrinol. Metab. 2, 670–680 (2006)
3. Brenneman, D. E. Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Peptides 28, 1720–1726 (2007)
4. Sherwood, N. M., Krueckl, S. L. & McRory, J. E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21, 619–670 (2000)
5. Gilligan, P. J. & Li, Y. W. Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases. Curr. Opin. Drug Discov. Devel. 7, 487–497 (2004)
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献